Literature DB >> 1654769

Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation.

A R Giuliano1, R T Franceschi, R J Wood.   

Abstract

The human colon carcinoma cell line, Caco-2, is the only intestinal cell line to spontaneously differentiate in culture to a population exhibiting structural and biochemical characteristics of mature enterocytes. We conducted studies to establish the presence of the vitamin D receptor (VDR), determine changes in VDR concentration and affinity with differentiation and determine whether 1 alpha,25-dihydroxyvitamin D3 (1,25(OH)2D3) mediates a functional response in this cell line. We found that Caco-2 cells possess a specific 1,25(OH)2D3 binding protein similar to the mammalian VDR. It has an equilibrium dissociation constant (Kd) of 0.72 nM, binds vitamin D analogues in order of their biological activities in vivo (1,25(OH)2D3 greater than 25(OH)D3 greater than 24,25(OH)2D3), sediments as a single peak on sucrose density gradients at 3.7 S, and is eluted from a DNA-cellulose column by 0.16 M KCl. The maximum number of binding sites was 2.6-fold greater in the differentiated cell (Day 15) compared to the preconfluent, undifferentiated (Day 4) cell (23 fmol/mg protein vs 56 fmol/mg protein). Cell growth was reduced 59% when exposed to 10(-7) M 1,25(OH)2D3 for 8 days. Alkaline phosphatase activity significantly increased in cultures incubated with 10(-8) M 1,25(OH)2D3 for up to 4 days when treatment was started in both undifferentiated cells (Day 5) and differentiated cells (Day 11). These findings suggest that the VDR present in undifferentiated and differentiated Caco-2 cells is functional. Caco-2 cells provide a unique in vitro model to study vitamin D-regulated functions in differentiated mammalian enterocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654769     DOI: 10.1016/0003-9861(91)90358-p

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  23 in total

1.  1,25-Dihydroxyvitamin D and 25-hydroxyvitamin D--mediated regulation of TRPV6 (a putative epithelial calcium channel) mRNA expression in Caco-2 cells.

Authors:  Shveta Taparia; James C Fleet; Ji-Bin Peng; Xiang Dong Wang; Richard J Wood
Journal:  Eur J Nutr       Date:  2005-12-21       Impact factor: 5.614

2.  Association of common gene variants in vitamin D modulating genes and colon cancer recurrence.

Authors:  Joanna Szkandera; Gudrun Absenger; Martin Pichler; Michael Stotz; Tanja Langsenlehner; Hellmut Samonigg; Wilfried Renner; Armin Gerger
Journal:  J Cancer Res Clin Oncol       Date:  2013-06-23       Impact factor: 4.553

3.  Vitamin D: marker or mechanism of action?

Authors:  Elizabeth T Jacobs; María Elena Martínez; Peter W Jurutka
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04       Impact factor: 4.254

4.  CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells.

Authors:  Elizabeth T Jacobs; Chad Van Pelt; Ryan E Forster; Wasiq Zaidi; Elizabeth A Hibler; Michael A Galligan; Mark R Haussler; Peter W Jurutka
Journal:  Cancer Res       Date:  2013-02-19       Impact factor: 12.701

5.  Effect of 17beta-oestradiol on transepithelial calcium transport in human intestinal-like Caco-2 cells and its interactions with 1,25-dihydroxycholecalciferol and 9-cis retinoic acid.

Authors:  A A Cotter; Kevin D Cashman
Journal:  Eur J Nutr       Date:  2006-02-20       Impact factor: 5.614

6.  Vitamin D receptor haplotypes protect against development of colorectal cancer.

Authors:  Jana Flügge; Solveigh Krusekopf; Mark Goldammer; Elena Osswald; Werner Terhalle; Uwe Malzahn; Ivar Roots
Journal:  Eur J Clin Pharmacol       Date:  2007-09-20       Impact factor: 2.953

7.  Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer.

Authors:  Linda T Hiraki; Conghui Qu; Carolyn M Hutter; John A Baron; Sonja I Berndt; Stéphane Bézieau; Hermann Brenner; Bette J Caan; Graham Casey; Jenny Chang-Claude; Stephen J Chanock; David V Conti; David Duggan; Charles S Fuchs; Steven Gallinger; Edward L Giovannucci; Tabitha A Harrison; Richard B Hayes; Aditi Hazra; Brian Henderson; Michael Hoffmeister; John L Hopper; Thomas J Hudson; Mark A Jenkins; Sébastien Küry; Loic Le Marchand; Mathieu Lemire; Jing Ma; Joann E Manson; Hongmei Nan; Polly A Newcomb; Kimmie Ng; John D Potter; Robert E Schoen; Fredrick R Schumacher; Daniela Seminara; Martha L Slattery; Jean Wactawski-Wende; Emily White; Kana Wu; Brent W Zanke; Peter Kraft; Ulrike Peters; Andrew T Chan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-27       Impact factor: 4.254

8.  Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential.

Authors:  H S Cross; K H Farsoudi; M Peterlik
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

9.  Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines.

Authors:  Marcy E Beildeck; Md Islam; Salimuddin Shah; Joellen Welsh; Stephen W Byers
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

10.  Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer.

Authors:  K Ng; B M Wolpin; J A Meyerhardt; K Wu; A T Chan; B W Hollis; E L Giovannucci; M J Stampfer; W C Willett; C S Fuchs
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.